Journal
MOLECULAR BIOLOGY OF THE CELL
Volume 17, Issue 4, Pages 1995-2008Publisher
AMER SOC CELL BIOLOGY
DOI: 10.1091/mbc.E05-09-0869
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL064917, P50 HL057144, P01 HL014985, HL 57144-09, HL 14985-33, HL 64917] Funding Source: Medline
Ask authors/readers for more resources
We have previously found that hypoxia stimulates proliferation of vascular fibroblasts through Gai-mediated activation of ERK1/2. Here, we demonstrate that hypoxia also activates the atypical protein kinase C zeta(PKC zeta) isozyme and stimulates the expression of ERK1/2-specific phosphatase, MAP kinase phosphatase-1 (MKP-1), which attenuates ERK1/2-mediated proliferative signals. Replication repressor activity is unique to PKC zeta because the blockade of classical and novel PKC isozymes does not affect fibroblast proliferation. PKC zeta is phosphorylated upon prolonged (24 h) exposure to hypoxia, whereas ERK1/2, the downstream kinases, are maximally activated in fibroblasts exposed to acute (10 min) hypoxia. However, PKC zeta blockade results in persistent ERK1/2 phosphorylation and marked increase in hypoxia-induced replication. Similarly prolonged ERK1/2 phosphorylation and increase in hypoxia-stimulated proliferation are also observed upon blockade of MKP-1 activation. Because of the parallel suppressive actions of PKC zeta and MKP-1 on ERK1/2 phosphorylation and proliferation, the role of PKC in the regulation of MKP-1 expression was evaluated. PKC zeta attenuation reduces MKP-1 expression, whereas PKC zeta overexpression increases MKP-1 levels. In conclusion, our results indicate for the first time that hypoxia activates PKC zeta, which acts as a terminator of ERK1/2 activation through the regulation of downstream target, MKP-1 expression and thus serves to limit hypoxia-induced proliferation of fibroblasts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available